Corrigendum to ‘Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma’
Titel:
Corrigendum to ‘Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma’
Auteur:
Sharon, C.E. Tortorello, G.N. Ma, K.L. Huang, A.C. Xu, X. Giles, L.R. McGettigan, S. Kreider, K. Schuchter, L.M. Mathew, A.J. Amaravadi, R.K. Gimotty, P.A. Miura, J.T. Karakousis, G.C. Mitchell, T.C.